Idarucizumab for reversing anticoagulation in adults treated with dabigatran a review of the clinical effectiveness, cost-effectiveness, and guidelines
This report was reviewed by experts in the treatment of venous thromboembolism and emergency medicine
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa, ON
Canadian Agency for Drugs and Technologies in Health
2017, 31 January 2017
|
| Series: | Rapid response report: peer-reviewed summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This report was reviewed by experts in the treatment of venous thromboembolism and emergency medicine |
|---|---|
| Item Description: | "CADTH Rapid Response Service." |
| Physical Description: | 1 PDF file (16 pages) illustration |